142 related articles for article (PubMed ID: 8765030)
1. Chemically induced sarcomas from nude mice are more immunogenic than similar sarcomas from congenic normal mice.
Svane IM; Engel AM; Nielsen MB; Ljunggren HG; Rygaard J; Werdelin O
Eur J Immunol; 1996 Aug; 26(8):1844-50. PubMed ID: 8765030
[TBL] [Abstract][Full Text] [Related]
2. Immune selection in murine tumors. Ph.d thesis.
Svane IM; Engel AM
APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
[TBL] [Abstract][Full Text] [Related]
3. H-2 antigens and tumour-associated transplantation antigens in clones derived from a methylcholanthrene-induced BALB/c tumour: their influence on the generation in vitro and in vivo of the specific anti-tumour immune response.
Pérez M; Garrido A; Algarra I; Caballero A; Delgado C; Collado MD; Fernández-Cruz E; Garrido F
Exp Clin Immunogenet; 1989; 6(3):204-18. PubMed ID: 2631798
[TBL] [Abstract][Full Text] [Related]
4. Major histocompatibility complex class I and unique antigen expression by murine tumors that escaped from CD8+ T-cell-dependent surveillance.
Ward PL; Koeppen HK; Hurteau T; Rowley DA; Schreiber H
Cancer Res; 1990 Jul; 50(13):3851-8. PubMed ID: 2112981
[TBL] [Abstract][Full Text] [Related]
5. Rejection of tumors in mice with severe combined immunodeficiency syndrome determined by the major histocompatibility complex. Class I expression on the graft.
Glas R; Waldenström M; Höglund P; Klein G; Kärre K; Ljunggren HG
Cancer Res; 1995 May; 55(9):1911-6. PubMed ID: 7728758
[TBL] [Abstract][Full Text] [Related]
6. Loss of marrow allograft resistance in mice with transplanted methylcholanthrene-induced sarcomas.
Kumar V; Bennett M
J Natl Cancer Inst; 1975 Aug; 55(2):489-92. PubMed ID: 240033
[TBL] [Abstract][Full Text] [Related]
7. CD8+ T cells are crucial for the ability of congenic normal mice to reject highly immunogenic sarcomas induced in nude mice with 3-methylcholanthrene.
Boesen M; Svane IM; Engel AM; Rygaard J; Thomsen AR; Werdelin O
Clin Exp Immunol; 2000 Aug; 121(2):210-5. PubMed ID: 10931133
[TBL] [Abstract][Full Text] [Related]
8. Methylcholanthrene-induced sarcomas in nude mice have short induction times and relatively low levels of surface MHC class I expression.
Engel AM; Svane IM; Mouritsen S; Rygaard J; Clausen J; Werdelin O
APMIS; 1996 Sep; 104(9):629-39. PubMed ID: 8972687
[TBL] [Abstract][Full Text] [Related]
9. Immunogenetic studies on the resistance of mice to highly metastatic DBA/2 tumor cell variants. I. Effect of incompatibilities at H-2 or non-H-2 genes in normal and nude (nu/nu) mice.
Schirrmacher V
Invasion Metastasis; 1981; 1(1):4-21. PubMed ID: 7188381
[TBL] [Abstract][Full Text] [Related]
10. Methylcholanthrene-induced mouse sarcomas express individually distinct major histocompatibility complex class I-associated peptides recognized by specific CD8+ T-cell lines.
Kono K; Petersson M; Ciupitu AM; Wen T; Klein G; Kiessling R
Cancer Res; 1995 Dec; 55(23):5648-55. PubMed ID: 7585649
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules.
Ohlén C; Höglund P; Sentman CL; Carbone E; Ljunggren HG; Koller B; Kärre K
Eur J Immunol; 1995 May; 25(5):1286-91. PubMed ID: 7774631
[TBL] [Abstract][Full Text] [Related]
12. Effects of IL-1 molecules on growth patterns of 3-MCA-induced cell lines: an interplay between immunogenicity and invasive potential.
Voronov E; Reich E; Dotan S; Dransh P; Cohen I; Huszar M; Fogel M; Kleinman HK; White RM; Apte RN
J Immunotoxicol; 2010 Mar; 7(1):27-38. PubMed ID: 20001788
[TBL] [Abstract][Full Text] [Related]
13. Rejection of K1735 murine melanoma in syngeneic hosts requires expression of MHC class I antigens and either class II antigens or IL-2.
Chen PW; Ananthaswamy HN
J Immunol; 1993 Jul; 151(1):244-55. PubMed ID: 8326126
[TBL] [Abstract][Full Text] [Related]
14. Induction of tumor-specific antitumor immunity after chemotherapy with cisplatin in mice bearing MOPC-104E plasmacytoma by modulation of MHC expression on tumor surface.
Nio Y; Hirahara N; Minari Y; Iguchi C; Yamasawa K; Toga T; Tamura K
Anticancer Res; 2000; 20(5A):3293-9. PubMed ID: 11062756
[TBL] [Abstract][Full Text] [Related]
15. Common transplantation antigens on methylcholanthrene-induced murine sarcomas detected by three assays of tumor rejection.
Leffell MS; Coggin JH
Cancer Res; 1977 Nov; 37(11):4112-9. PubMed ID: 908044
[No Abstract] [Full Text] [Related]
16. Studies of allogeneic tumor transplants: induced rejection of advanced tumors by immune alteration of recipients.
Russell PS; Chase CM; Burton RC
J Immunol; 1983 Feb; 130(2):951-7. PubMed ID: 6336775
[TBL] [Abstract][Full Text] [Related]
17. Destructive and nondestructive patterns of immune rejection of syngeneic intraocular tumors.
Knisely TL; Luckenbach MW; Fischer BJ; Niederkorn JY
J Immunol; 1987 Jun; 138(12):4515-23. PubMed ID: 3108394
[TBL] [Abstract][Full Text] [Related]
18. Properties of a M(r) 110,000 tumor rejection antigen of the chemically induced BALB/c Meth A sarcoma.
De Leo AB; Becker M; Lu L; Law LW
Cancer Res; 1993 Apr; 53(7):1602-7. PubMed ID: 7680955
[TBL] [Abstract][Full Text] [Related]
19. Genetic control of in vitro NK-activity and in vivo resistance to tumors.
Kärre K; Klein GO; Kiessling R; Klein G
Tokai J Exp Clin Med; 1983 Dec; 8(5-6):429-48. PubMed ID: 6681339
[TBL] [Abstract][Full Text] [Related]
20. Enhanced expression of class I major histocompatibility complex gene (Dk) products on immunogenic variants of a spontaneous murine carcinoma.
Carlow DA; Kerbel RS; Feltis JT; Elliott BE
J Natl Cancer Inst; 1985 Aug; 75(2):291-301. PubMed ID: 2410653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]